Isn't it time to consider oncological status as a new risk factor of iodinated contrast media hypersensitivity?

Conclusions. A high proportion of oncological patients was observed in our population with HS to ICM. They did not have other known risk factors, and they were less atopic. Larger multicentric studies should explore cancer as a potential new risk factor.PMID:35029101 | DOI:10.23822/EurAnnACI.1764-1489.242

Source: European Annals of Allergy and Clinical Immunology - January 14, 2022 Category: Allergy & Immunology Authors: P Dellis F Pirson Source Type: research